Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:07pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Omeros Corporation (OMER)
At 5:00AM SGT:
5.69 USD
0.00 (0.00%)
MORE ON OMER
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Omeros Corporation
(NGM:OMER) Delayed quote data
Last Trade:
5.69 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
5.69
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
11.80
Day's Range:
N/A - N/A
52wk Range:
5.27 - 9.49
Volume:
0
Avg Vol
(3m)
:
45,754
Market Cap:
121.04M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-7.48
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
Use Y! Toolbar to track stocks
Add OMER to Portfolio
Download Data
HEADLINES
Omeros Announces National Institute on Drug Abuse's Support for Phase 2 Clinical Study in Addiction Program
PR Newswire
(Thu, Jan 28)
After A Sluggish Year, VCs Eye Improvement
Investor's Business Daily
(Sat, Jan 9)
IPO comeback in 2009 sets stage for busy 2010
AP
(Fri, Jan 1)
The Worst IPOs Of 2009
at Investopedia
(Thu, Dec 17)
Worst IPOs of 2009: Biggest Stock Flops
at TheStreet.com
(Tue, Dec 15)
OMEROS CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
(Wed, Dec 9)
Coverage initiated on Omeros by Needham
Briefing.com
(Tue, Dec 1)
New Star Analyst Rankings for Omeros Corporation
StarMine
(Sun, Nov 22)
OMEROS CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online
(Fri, Nov 20)
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
PR Newswire
(Fri, Nov 20)
More Headlines for OMER...
ANALYST
EPS Est (next year)
(Dec-09)
:
-1.44
EPS Est (in 2 years)
(Dec-10)
:
-1.41
Avg Rec (current)*:
1.6
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Omeros Corporation, a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing products on inflammation and disorders of the central nervous system.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices